跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Ernafil Tablet 100 mg - HSA Drug Approval Details
Approvals
/
HSA
/
Ernafil Tablet 100 mg
Approved
THERAPEUTIC
Ernafil Tablet 100 mg
Actavis Ltd.
🇸🇬 Health Sciences Authority
Approval Date
May 18, 2012
Approval ID
056529778a5d0d9c
Company
Actavis Ltd.
Type
Therapeutic
Approval Details
Approval Id
056529778a5d0d9c
Drug Name
Ernafil Tablet 100 mg
Product Name
Ernafil Tablet 100 mg
Approval Number
SIN14151P
Approval Date
2012-05-18
Registrant
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Licence Holder
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
Prescription Only
Dosage Form
TABLET, FILM COATED
Route Of Administration
ORAL
Atc Code
G04BE03
Atc Item Name
sildenafil
Pharma Manufacturer Name
TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.
Company Detail Path
/organization/teva-pharmaceutical-investments-singapore-pte-ltd
Active Ingredients
Sildenafil citrate 140.48 mg corresponding to sildenafil base
100.00 mg
SILDENAFIL CITRATE 140.48 MG CORRESPONDING TO SILDENAFIL BASE
100 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
May 18, 2012
Approval ID
056529778a5d0d9c
Type
Therapeutic
Back to HSA Approvals